Eating behaviors in obese children with pseudohypoparathyroidism type 1a: a cross-sectional study by unknown
Wang and Shoemaker International Journal of Pediatric Endocrinology 2014, 2014:21
http://www.ijpeonline.com/content/2014/1/21RESEARCH Open AccessEating behaviors in obese children with
pseudohypoparathyroidism type 1a:
a cross-sectional study
Lulu Wang1 and Ashley H Shoemaker2*Abstract
Background: Children with pseudohypoparathyroidism type 1a (PHP-1a) develop early-onset obesity. These
children have decreased resting energy expenditure but it is unknown if hyperphagia contributes to their obesity.
Methods: We conducted a survey assessment of patients 2 to 12 years old with PHP-1a and matched controls
using the Hyperphagia Questionnaire (HQ) and Children’s Eating Behavior Questionnaire (CEBQ). Results of the
PHP-1a group were also compared with an obese control group and normal weight sibling group.
Results: We enrolled 10 patients with PHP-1a and 9 matched controls. There was not a significant difference
between the PHP-1a group and matched controls for total HQ score (p = 0.72), Behavior (p = 0.91), Drive (p = 0.48)
or Severity (p = 0.73) subset scores. There was also no difference between the PHP-1a group and matched controls
on the CEBQ. In a secondary analysis, the PHP-1a group was compared with obese controls (n = 30) and normal
weight siblings (n = 6). Caregivers reported an increased interest in food before age 2 years in 6 of 10 PHP-1a
patients (60%), 9 of 30 obese controls (30%) and none of the siblings (p = 0.04). The sibling group had a significantly
lower Positive Eating Behavior score than the PHP-1a group (2.6 [2.4, 2.9] vs. 3.5 [3.1, 4.0], p < 0.01) and obese
controls (2.6 [2.4, 2.9] vs. 3.4 [2.6, 3.8], p = 0.04), but there was not a significant difference between the PHP-1a
and obese controls (p = 0.35). The sibling group had a lower Desire to Drink score than both the PHP-1a group
(1.8 [1.6, 2.7] vs. 4.3 [3.3, 5.0], p < 0.01) and obese controls (1.8 [1.6, 2.7] vs. 3.3 [3.0, 4.0], p < 0.01) but there was not a
significant difference between the PHP-1a and obese control Desire to Drink scores (p = 0.11).
Conclusions: Patients with PHP-1a demonstrate hyperphagic symptoms similar to matched obese controls.
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Pseudohypoparathyroidism type 1a (PHP-1a) is a rare
disorder caused by a maternally inherited mutation in
the gene GNAS. GNAS encodes the alpha subunit of the
stimulatory G-protein (Gsα). In some tissues, the pater-
nal allele is imprinted and only the maternal allele is
expressed. Therefore, in imprinted tissues, patients with
PHP-1a lack functional Gsα and have abnormal G-protein
coupled receptor signaling. Examples of known imprinted
tissues include kidney, thyroid, hypothalamus and pitui-
tary [1-3]. PHP-1a is usually diagnosed in childhood due* Correspondence: Ashley.H.Shoemaker@vanderbilt.edu
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article, unless otherwise stated.to a distinctive phenotype that includes short stature, bra-
chydactyly, cognitive impairment, ectopic ossifications
and multi-hormone resistance.
A more recently described feature of PHP-1a is early-
onset obesity [4]. This obesity occurs despite adequate
treatment of hormone deficiencies, including thyroid
hormone and growth hormone replacement. A current
hypothesis is that the obesity phenotype is due to abnor-
mal function of the melanocortin-4 receptor (MC4R) in
the hypothalamus. The MC4R is a G-protein coupled re-
ceptor that plays a critical role in energy homeostasis.
Mutations in MC4R are the most common cause of
monogenic obesity in humans [5].
In a previous study, we showed that children with
PHP-1a have decreased resting energy expenditure whichd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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is seen in humans and mice with abnormal MC4R signal-
ing [5,7] but has not been demonstrated in the PHP-1a
mouse model [1]. It is not known if hyperphagia or abnor-
mal eating behaviors are seen in children with PHP-1a.
We hypothesized that children with PHP-1a have mild hy-
perphagia leading to excess caloric intake and abnormal
weight gain. To test this hypothesis, we measured eating
behaviors and hyperphagia in children with PHP-1a and
matched controls.Methods
Participants
Study participants were recruited from the Vanderbilt
adult and pediatric endocrinology clinics as well as on-
line advertisements from August, 2012 through January,
2014. Inclusion criteria were age 2–12 years old, English
proficiency and one of the following: clinical diagnosis of
PHP-1a or status as a sibling of a PHP-1a patient. Exclu-
sion criteria were: obesity due to another known genetic
syndrome (e.g., Prader-Willi syndrome) or current use of
appetite-suppressing medications.
Healthy, matched controls were recruited from the
Vanderbilt pediatric clinics and the Vanderbilt Childhood
Obesity Registry (VCOR). VCOR is a registry for patients
with a history of BMI >97th percentile before 6 years old.
Controls were matched based on gender, age (±2 years)
and BMI Z-score (±0.25). All patients in VCOR age 2–12
years old were included in the general obese control
group.
Consent and age appropriate assent were obtained. The
study was approved by the Institutional Review Board of
Vanderbilt University.Experimental procedure
All participants completed a medical history form. Chil-
dren’s height and weight were obtained from the most
recent endocrinology or primary care clinic visit. BMI
height and weight z-scores were calculated as standard
deviations from the mean using gender and age specific
Centers for Disease Control growth charts. All children
had a Hyperphagia Questionnaire (HQ) [8] and Chil-
dren’s Eating Behavior Questionnaire (CEBQ) [9] com-
pleted by the primary caregiver.
The HQ was originally developed to assess hyperpha-
gia in Prader-Willi syndrome and contains 11-questions
that assess symptoms of hyperphagia in one of three
categories (Behavior, Drive and Severity), as rated on a
five-point scale (1 = not a problem to 5 = severe and/or
frequent problem). The total HQ score has a minimum
of 11 points and a maximum of 55. The 35-item CEBQ
assesses Positive and Negative Eating Behaviors. The
Positive Eating Behavior score is comprised of foursub-scales: Food Responsiveness, Enjoyment of Food,
Emotional Overeating and Desire to Drink.
Data collection
Study data were collected and managed using REDCap
electronic data capture tools hosted at Vanderbilt Uni-
versity. REDCap (Research Electronic Data Capture) [10]
is a secure, web-based application designed to support
data capture for research studies. Questionnaires were
completed either online (REDCap survey) or via mail.
Statistical analysis
The primary outcome was the subset scores of the HQ
in PHP-1a patients compared with matched controls.
Secondary analyses include comparison of CEBQ subset
scores and comparison of PHP-1a, sibling and obese
control groups. Results are presented as median (inter-
quartile range) unless otherwise specified. Paired analysis
was done using Wilcoxon signed rank test. For the sec-
ondary analysis of the three groups (PHP-1a, obese con-
trols and sibling controls), continuous variables were
compared using the Kruskal-Wallis test. If the p value
was <0.05, each group was compared using the Mann–
Whitney U test. Categorical variables were compared
using Chi-square test. Based on our sample size, we did
not use regression or analyses of covariance due to con-
cerns for over-fitting. Internal consistency of the HQ
was assessed using Cronbach’s alpha. Statistics were per-
formed using SPSS version 22.
Results
Study population
Ten patients with PHP-1a enrolled in the study, inclu-
ding 2 sibling pairs. We identified a matched control for
9 of 10 PHP-1a patients. We enrolled all unaffected sib-
lings (n = 6) to serve as a normal weight control group.
The two PHP-1a sibling pairs and one additional PHP-
1a subject did not have an unaffected sibling. An add-
itional 21 obese children between 2 and 12 years old had
questionnaire data available in VCOR. These children
were combined with the matched controls to form an
obese control group (n = 30) for secondary analysis.
Baseline characteristics
Patients were matched on age, gender and BMI z-score
(Table 1). All PHP-1a patients were white and 6 of 9
matched controls where white, the remaining patients
were African American. Table 2 summarizes the baseline
characteristics of the subjects. The PHP-1a group age
range was 2 to 10 years old, the obese control group was
3 to 12 years old and the sibling control group was 3 to
12 years old. As expected, the PHP-1a and obese control
groups were significantly more obese than the sibling
controls as measured by BMI z-score (p <0.01) but there
Table 1 Baseline characteristic of the matched pairs
Patient PHP-1a group Matched control
Age BMI z-score Age BMI z-score
1 2 3.33 --- ---
2 3 1.71 3 1.54
3 4 1.16 4 1.08
4 5 2.78 7 2.72
5 5 1.44 5 1.39
6 6 2.98 5 3.01
7 9 3.01 9 2.95
8 9 2.41 10 2.44
9 10 1.85 11 1.74
10 10 2.70 10 2.63
PHP-1a, pseudohypoparathyroidism type 1a; BMI, body mass index. BMI
z-scores were calculated as standard deviations from the mean using gender
and age specific Centers for Disease Control growth charts.
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groups (p = 0.86). The obese control group was 57% white
and 43% African American versus the PHP-1a group that
was 100% white (p = 0.02).
Hyperphagia questionnaire
There was not a significant difference between the PHP-1a
group and matched controls for total HQ score (p = 0.72),
Behavior (p = 0.91), Drive (p = 0.48) or Severity (p = 0.73)
(Figure 1). Two PHP-1a patients were outliers with total
HQ scores of 39 and 40 (group median 22.5 [17.3, 32.3])
though they were not more obese than the overall group
(BMI z-score 2.78 and 2.41, group median 2.55 [1.64,
2.99]). There was also not a significant difference between
the PHP-1a, obese control and sibling groups for total HQ
score (22.5 [17.3, 32.3] vs. 18.5 [15.8, 27.0] vs. 18.5 [17.3,
20.3], p = 0.40) or subset scores (Figure 2). The HQ in-
cludes a question “how old was your child when they first
showed an increased interest in food” that is not included
in the HQ score. Caregivers reported an increased interest
in food before age 2 years in 6 of 10 PHP-1a patients
(60%), 9 of 30 obese controls (30%) and none of the sib-
lings (p = 0.04). Internal reliability coefficients (Cronbach’s
alpha) were 0.86 for the total HQ score, 0.64 for Behavior,
0.84 for Drive and 0.72 for Severity.Table 2 Baseline characteristics
PHP-1a (n = 10) Obese controls (n
Age (years) 5.5 (3.8, 9.3) 7.0 (5.0-10.0)
Gender (% female) 60 70
Ethnicity (% white) 100 57
BMI 24.5 (18.2, 30.5) 29.5 (21.6, 35.1
BMI Z-score 2.55 (1.64, 2.99) 2.50 (1.74, 2.84
PHP-1a, pseudohypoparathyroidism type 1a; BMI, body mass index. Data expressed
Mann-Whitney U test and Fisher’s Exact test, comparing the PHP-1a group with eac
mean using gender and age specific Centers for Disease Control growth charts. *BMChildhood eating behavior questionnaire
There was no significant difference between the PHP-1a
group and matched controls for Negative Eating Behav-
iors (2.9 [2.8, 3.2] vs. 2.9 [2.6, 3.2], p = 0.77) or Positive
Eating Behaviors (3.5 [2.9, 4.2] vs. 3.4 [3.1, 3.7], p = 0.86).
The subscale scores for Food Responsiveness (p = 1.0),
Enjoyment of Food (p = 0.81), Emotional Overeating
(p = 0.73) and Desire to Drink (p = 0.31) were not diffe-
rent between matched pairs (Figure 3). One obese con-
trol patient did not have CEBQ data available; therefore
29 obese control subjects were included for this sub-
analysis (Figure 4). The sibling group had a significantly
lower Positive Eating Behavior score than the PHP-1a
group (2.6 [2.4, 2.9] vs. 3.5 [3.1, 4.0], p < 0.01) and obese
controls (2.6 [2.4, 2.9] vs. 3.4 [2.6, 3.8], p = 0.04), but
there was not a significant difference between the PHP-
1a and obese controls (p = 0.35). There was a difference
between the PHP-1a, obese control and sibling groups
for the Desire to Drink subscale (p < 0.01, Figure 4). The
sibling group had a lower Desire to Drink score than both
the PHP-1a group (1.8 [1.6, 2.7] vs. 4.3 [3.3, 5.0], p < 0.01)
and obese controls (1.8 [1.6, 2.7] vs. 3.3 [3.0, 4.0], p <
0.01). There was not a significant difference between the
PHP-1a and obese control Desire to Drink scores (p =
0.11).
Discussion
To our knowledge, this is the first study to systematically
evaluate eating behaviors in children with PHP-1a. While
MC4R haploinsufficiency is associated with marked hyper-
phagia [5,11], our data suggest that children with PHP-1a
may not be hyperphagic when compared with other obese
children. Similarly, the PHP-1a mouse model shows in-
creased feed efficiency, not increased food intake [1,2]. A
recent study in adults found no difference in energy intake
between PHP-1a and matched controls using 7-day food
records [12]. There is one published case series of parent
reported hyperphagia in two young children with PHP-1a
[13]. The variability seen in PHP-1a could be due to vari-
able imprinting of MC4R in the hypothalamus, or hy-
perphagia in MC4R haploinsufficiency may be mediated
through non-Gsα signaling pathways. Previously, we have
demonstrated that these children have decreased resting= 30) p value Siblings (n = 6) p value
0.22 7.5 (4.5, 11.3) 0.43
0.70 100 0.23
0.02 100 1.0
) 0.43 *18.4 (14.8, 22.8) 0.05
) 0.86 *0.48 (−0.72, 1.16) <0.01
as median (lower quartile, upper quartile). P-values were determined using
h control group. BMI z-scores were calculated as standard deviations from the
I data was not available for 2 siblings.
Figure 1 Hyperphagia questionnaire scores, total and subset, in children with pseudohypoparathyroidism type 1a (PHP-1a, circles) and
matched controls (squares). There was no significant difference between groups by Mann–Whitney U test (Total HQ score p = 0.72, Behavior
p = 0.91, Drive p = 0.48 or Severity p = 0.73). Values shown are median ± interquartile range.
Figure 2 Hyperphagia questionnaire scores, total and subset, in children with pseudohypoparathyroidism type 1a (PHP-1a, circles),
obese controls (squares) and siblings (triangles). There was no significant difference between groups by Kruskal Wallis test (Total HQ score
p = 0.40, Behavior p = 0.60, Drive p = 0.31 or Severity p = 0.43). Values shown are median ± interquartile range.
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Figure 3 Childhood eating behavior questionnaire positive eating behavior subset scores in children with pseudohypoparathyroidism
type 1a (PHP-1a, circles) and matched controls (squares). There was no significant difference between groups by Mann–Whitney U test
(Food Responsiveness p = 1.0, Enjoyment of Food p = 0.81, Emotional Overeating p = 0.73 and Desire to Drink p = 0.31). Values shown are
median ± interquartile range.
Figure 4 Childhood eating behavior questionnaire positive eating behavior subset scores in children with pseudohypoparathyroidism
type 1a (PHP-1a, circles), obese controls (squares) and siblings (triangles). Values shown are median ± interquartile range. *Indicates
p value <0.05 by Mann–Whitney U test following a significant Kruskal-Wallis test.
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lance may be the main driver of early-onset obesity in
PHP-1a.
The HQ has previously been used to evaluate eating
behaviors in other forms of syndromic obesity. The HQ
scores for PHP-1a (mean ± SD, total: 24.8 ± 8.9, behavior:
10.0 ± 4.5, drive: 11.1 ± 3.6, severity: 3.7 ± 2.5) were signifi-
cantly lower than Prader-Willi syndrome (total: 30.5 ± 5.8,
behavior: 13.6 ± 4.5, drive: 12.3 ± 3.3, severity: 4.6 ± 1.7) [8],
but only slightly lower than brain-derived neurotrophic
factor (BDNF) haploinsufficiency (total: 26.3 ± 7.3, behav-
ior: 10.6 ± 3.2, drive: 11.5 ± 3.4, severity: 4.2 ± 1.7) [14] and
Bardet-Biedl syndrome (total: 27.3 ± 8.2, behavior: 12.3 ±
3.8, drive: 11.1 ± 3.7, severity 3.9 ± 1.6) [8,15]. In contrast
with PHP-1a [1,2], mouse models of Bardet-Biedl syn-
drome [16,17] and Bdnf inactivation [18] demonstrate
obesity from increased food intake. It is possible that
PHP-1a patients are only hyperphagic during specific
developmental periods. Rapid weight gain in infancy and
parent reported “increased interest in food” at a young
age may indicate early, non-progressive hyperphagia in
PHP-1a.
PHP-1a and obese controls had increased Positive
Eating Behavior and Desire to Drink scores compared
with lean siblings, but not compared with obese con-
trols. Heightened preference for and consumption of
sugar-sweetened beverages has been linked to increased
Desire to Drink scores in children [19] and the motiv-
ation for drinking may be desire for the pleasant sensa-
tion of sweet taste. Alternatively, these children may
demonstrate a drive for high caloric foods, aided by con-
sumption of sugar-sweetened beverages. A reduction in
the intake of sugar-sweetened beverages may be an ef-
fective strategy to reduce the rate of weight gain in obese
children [20,21].
The main limitation of our study was the small sample
size. PHP-1a is a rare disorder and it is challenging
to identify eligible subjects. We used a matched control
group in order to account for possible confounders with-
out over-fitting our statistical model, but a matched con-
trol was not available for one child with PHP-1a. In
addition, controls were not matched based on race and
this may have masked differences between the groups.
The HQ was originally designed for children with Prader-
Willi syndrome but we believe that it is an appropriate
tool for PHP-1a as both disorders cause intellectual dis-
ability, multiple medical problems and childhood obesity.
An advantage of this questionnaire is that it is completed
by the parent which allows the investigation of eating
behaviors in young children and those with intellectual
disability. The Cronbach’s alpha results for our study
population (range 0.64-0.86) were all acceptable and simi-
lar to those in the original study of Prader-Willi syndrome
(range 0.60-0.80) [8].Conclusion
In summary, our data suggest that children with PHP-1a
demonstrate hyperphagic symptoms similar to other obese
children. The mild hyperphagia seen in PHP-1a may be
common in obese children and not attributable to PHP-
1a. Further studies, such as standardized test meals and
longitudinal investigations, are needed to confirm our fin-
dings. Understanding the pathophysiology of abnormal
weight gain in children with PHP-1a may inform our un-
derstanding of energy homeostasis in humans and is crit-
ical in order to design targeted therapeutic interventions.
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